Vascular Changes Persist After Multisystem Inflammatory Syndrome in Children

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

THURSDAY, Jan. 18, 2024 -- Multisystem inflammatory syndrome in children (MIS-C) may be associated with an increased risk for future cardiovascular complications due to significant persistent vascular alterations, according to a research letter published online Jan. 16 in JAMA Pediatrics.

Julie Boever, from Ludwig Maximilian University of Munich, and colleagues conducted a case-control study of 17 patients with MIS-C and 17 matched controls with a median follow-up of 114.5 days.

The researchers found that during the acute phase, patients with MIS-C showed significantly damaged microcirculation, including lower median microvascular flow index (2.36 versus 2.80), total vessel density (16.14 versus 19.61 mm/mm2), and proportion of perfused vessels (12.31 versus 18.10 percent) compared with controls. There was alteration of vessel diameter distribution with significant capillary rarefication. Even without ongoing inflammation, impaired microcirculatory parameters persisted during follow-up. These findings persisted when adjusting for age, body mass index, and sex. In MIS-C, the augmentation index was significantly increased only during follow-up (median, −7.05 versus −18.01).

"This study emphasizes the importance of understanding the vascular impact of MIS-C during the acute phase and follow-up period to provide appropriate medical care and interventions," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-19 22:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords